| 產(chǎn)品編號(hào) | bs-44020P |
| 英文名稱 | Recombinant SARS-Cov-2 N protein (EG.5/BA.4/BA.4.6)（P13L，DEL31-33，R203K，G204R，S413R）,N-His |
| 中文名稱 | 重組SARS冠狀病毒2核衣殼突變體蛋白 |
| 別 名 | SARS-CoV-2 Nucleocapsid Protein; SARS-CoV-2 NP; nucleocapsid protein [Severe acute respiratory syndrome coronavirus 2]; novel coronavirus N Protein; novel coronavirus Nucleocapsid Protein; 2019-nCoV Nucleoprotein; 2019-nCoV N; 2019nCoV N; 2019-nCoV N Protein; 2019 ncov N Protein; 2019-nCoV nucleocapsid protein |
| 理論分子量 | 47.1kDa |
| 性 狀 | Lyophilized or Liquid |
| 濃 度 | >0.5mg/ml |
| 物 種 | SARS-CoV-2 |
| 序 列 | 1-419/419 |
| 純 度 | >90% as determined by SDS-PAGE |
| 純化方法 | AC |
| 內(nèi)毒素 | Not tested |
| 表達(dá)系統(tǒng) | E.coli |
| 標(biāo)簽 | N-His |
| 緩 沖 液 | 20mM Tris-Hcl (pH=8.0) with 150mM Nacl |
| 保存條件 | Stored at -70℃ or -20℃. Avoid repeated freeze/thaw cycles. |
| 注意事項(xiàng) | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
| 產(chǎn)品介紹 | The SARS-CoV-2 spike (S) protein is the target of vaccine design efforts to end the COVID-19 pandemic. Despite a low mutation rate, isolates with the D614G substitution in the S protein appeared early during the pandemic, and are now the dominant form worldwide. Here, we analyze the D614G mutation in the context of a soluble S ectodomain construct. SWISS: P0DTC2 Gene ID: 43740568 Anti-SARS-CoV-2 Spike Protein S（IgM校準(zhǔn)品） 特性：人源單抗(雙鏈抗體)，親和力高，批次質(zhì)量穩(wěn)定 識(shí)別位置：新冠病毒S蛋白R(shí)BD區(qū)域 產(chǎn)品應(yīng)用：ELISA、膠體金層析、化學(xué)發(fā)光等 儲(chǔ)存條件：-20℃保存，避免反復(fù)凍融。 |
| 產(chǎn)品圖片 |  The purity of the protein is greater than 90% as determined by reducing SDS-PAGE. |
我要詢價(jià)
*聯(lián)系方式：
(可以是QQ、MSN、電子郵箱、電話等，您的聯(lián)系方式不會(huì)被公開(kāi))
*內(nèi)容：
